A new technique has been developed that decreases the expenses associated with drug manufacturing while simultaneously improving the stability of pharmaceuticals.
A revolutionary blood test for Alzheimer’s disease is expected to be introduced in Australia soon, aiming to enhance diagnostic methods for the condition.
Medical professionals are encouraged to adjust asthma treatment strategies as a significant shortage of Ventolin nebules is anticipated to persist until 2026.